18 results
8-K
EX-3.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Unicycive Announces $50 Million Private Placement
4:28pm
8-K
EX-3.4
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.6
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.3
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.2
cd4 9gmnd4in9zf49pu
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.5
7kee i8cw3uguaihjcta
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.1
lkm gasqr
6 Mar 23
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
5:02pm
S-1/A
EX-3.3
d2h oljiqzk6fw
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-3.1
sl2w85532dzeuv6il
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-3.2
rmfrw zq81v119gn
7 Jun 21
IPO registration (amended)
7:01am
S-1
EX-3.4
tmclxzte p2c5
21 May 21
IPO registration
4:07pm
S-1
EX-3.5
4t8nqgf
21 May 21
IPO registration
4:07pm
DRS/A
EX-3.2
rfeld os269l5y
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.1
obj9sl6 7js
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.3
9dn54qn8b9aoqaxs18
29 Apr 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next